AI Summary & Key Takeaways
AI InsightConclusion: We report that the vast majority of patients use oral anticoagulants (OAC), but, unfortunately it has also been found that, there are a considerable number of patients who are still not treated or receive incomplete treatment.
📌 3 Key Takeaways
Abstract
Objectives: Atrial fibrillation (AF) is the most commonly detected arrhythmia and is associated with a 5-fold increase in thromboembolic event rate. There is insufficient data in the literature about the frequency of referral to the hospital due to non-valvular AF, the presence of risk factors, and the choice of applied anticoagulant-antithrombotic treatment in the Yozgat population. In this study, we aimed to evaluate the demographic characteristics, the choice of anticoagulant-antithrombotic treatment, and the risk factors for ischemic stroke of the patients with non-valvular AF in Yozgat province. Methods: This was a single center retrospective study. The cases were consecutive AF patients, who were followed-up by the Cardiology outpatient clinic of Bozok University, Faculty of Medicine. A total of 316 non-valvular AF patients over 18 years old, were retrospectively evaluated. Baseline demographic characteristics, stroke risk factors and the data of antiplatelet and anticoagulant therapy were recorded. Results: One-hundred-thirty (41%) of the patients were male and 186 (59%) were female. The mean age of the patients was 67,5±12,9 years. The mean CHA2DS2-VASC score was found to be 3.2 ± 1.3. The most common stroke risk factors associated with AF were; age, hypertension, vascular diseases, heart failure and diabetes mellitus, respectively. Conclusion: We report that the vast majority of patients use oral anticoagulants (OAC), but, unfortunately it has also been found that, there are a considerable number of patients who are still not treated or receive incomplete treatment.
Özet
Amaç: Atriyal fibrilasyon (AF) en sık saptanan kardiyak aritmi olup tromboembolik olay oranında 5 kat artış-la ilişkilidir. Yozgat popülasyonunda non-valvüler AF nedeniyle hastaneye başvuru sıklığı, risk faktörlerininvarlığı, uygulanan antikoagülan–antitrombotik tedavinin seçimi hakkında literatürde yeterli veri yoktur. Buçalışmada, Yozgat ilinde yaşayan non-valvüler AF’li hastaların demografik özelliklerini, antikoagülan–antit-rombotik tedavi seçimini ve iskemik inme gelişim riskini değerlendirmeyi amaçladık.Metod: Bozok Üniversitesi Tıp Fakültesi Hastanesi Kardiyoloji polikliniğine başvuran 18 yaş üstü non-valvüler AF tanılı 316 kişinin bilgileri retrospektif olarak incelendi. Hastaların bazal demografik verileri, inmerisk faktörleri ve kullanmış oldukları antiagregan–antikoagülan tedavileri değerlendirildi.Bulgular: Hastaların 130’u (%41) erkek ve 186’sı (%59) kadın bireylerden oluşmaktaydı. Hastaların yaş orta-laması 67,5±12,9 yıldı. Ortalama CHA2DS2-VASC skoru 3,2±1,3 olarak bulundu. AF’ye eşlik eden inme riskfaktörleri sıklık sırasına göre yaş, hipertansiyon, vasküler hastalıklar, kalp yetmezliği ve diyabetes mellitusolarak bulundu.Sonuç: Hastaların büyük çoğunluğunun oral antikoagülan (OAK) kullandığı gözlenmiştir. Fakat hala azım-sanmayacak şekilde OAK tedavisi almayan ya da eksik tedavi alan hastalarında olduğu da tespit edilmiştir.